Latest Lilly Stories
INDIANAPOLIS, Dec. 15, 2014 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) today announced a 2 percent increase in its quarterly dividend.
FIRST OF SEVERAL PHASE 3 TRIALS TO REPORT RESULTS INDIANAPOLIS, Dec.
Phase II/III trial of AZD3293, an oral potent small molecule inhibitor of BACE, aims to enroll more than 1,500 patients in 15 countries INDIANAPOLIS, Dec.
Once-weekly treatment for adults with type 2 diabetes comes in a pen with a no-see, no-handle needle INDIANAPOLIS, Nov.
Lilly Foundation matches donations from Lilly and Elanco employees, retirees to support children, families in the U.S. and Puerto Rico INDIANAPOLIS, Oct.
Significant portion of alliance opportunity will remain unchanged; some countries will transition to exclusive promotion in 2015 INDIANAPOLIS and INGELHEIM, Germany, Oct.
INDIANAPOLIS, Oct. 23, 2014 /PRNewswire/ -- -- Third-quarter 2014 revenue declined 16 percent driven by the impact of U.S.
Broad Bi-Specific Antibody Collaboration Now Includes Targets that Could Lead to New Cancer Immunotherapies INDIANAPOLIS and VANCOUVER, Oct. 22, 2014 /CNW/ - Zymeworks Inc.
- A hairdresser.